The subgroup of EBV negative, MSS and wild-type TP53 tumours comprised 28.0% (52/186) of the intestinal-type tumours and 80.8% (42/52) of the diffuse-type tumours in our study population. The gene discussed is TP53; the disease is neoplasm.